Additionally, GnRH immunocastration might trigger compensatory hormonal responses, possibly increasing aromatase activity in brain areas like the hypothalamus, hippocampus, and amygdala, leading to elevated local estrogen levels that help mitigate anxiety and depression [40]. Here, CYP19A1 is linked to depressive symptom measurement.